Use of fosfomycin combination therapy to treat multidrug-resistant urinary tract infection among paediatric surgical patients - a tertiary care centre experience

Access Microbiology
Shiju K SKumaravel S

Abstract

With increasing resistance to currently used antibiotics, antibiotic combinations are being resorted to. The present study deals with five children with complicated urinary tract infection (UTI) whose urine cultures grew multidrug-resistant (MDR) organisms. In all of these five cases, MDR organisms were the causative agents for UTI and the currently available antibiotics, including colistin, were ineffective, although the organisms were sensitive in vitro. In all of these cases, the isolates reverted to being susceptible to the quinolones and cephalosporins tested, namely ceftriaxone and ceftazidime. All were treated using a combination of fosfomycin with other antibiotics, since it has no interference with other classes of antibiotics. Our observations suggest that the use of a combination of fosfomycin with either a carbapenem or an aminoglycoside in a clinical setting would be a reasonable choice to treat UTIs caused by MDR organisms, especially in complicated cases that require chronic therapy.

References

Apr 17, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Mitsuhiro OkazakiTakashi Watanabe
Sep 13, 2005·International Journal of Antimicrobial Agents·Romolo J GaspariGary Doern
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E FalagasPetros I Rafailidis
Aug 19, 2009·Antimicrobial Agents and Chemotherapy·Sofia MarakiMatthew E Falagas
Feb 23, 2010·The Journal of Urology·Koji ShiraishiSaburo Tanikaze
Dec 3, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Tsung-Hua WuPo-Yen Chen
Nov 9, 2016·Antimicrobial Agents and Chemotherapy·Deanna J BuehrleM Hong Nguyen
Mar 18, 2017·Journal of Microbiology and Biotechnology·Keehoon Lee, Sang Sun Yoon
Nov 1, 2017·Antibiotics·Anneke Corinne DijkmansIngrid Maria Catharina Kamerling
Dec 10, 2017·Journal of Vascular and Interventional Radiology : JVIR·Sphoorti ShellikeriAnne Marie Cahill
Aug 3, 2019·Infection and Drug Resistance·Pallam GopichandL N Dorairajan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.